News- Vaccines

Date of Publish	Newspaper/ Channel	Title	Summary	Reference paper Title/link
2021 Apr 19	BBC	Covid-19 vaccines: What's happening to unused jabs?
2021 Apr 07	BBC	EU drug regulator: Unusual blood clot is 'very rare AstraZeneca side effect'
2021 Apr 16	BBC	Covid: How does the Oxford-AstraZeneca vaccine work?
2021 Apr 07	BBC	Covid vaccine update: Those that work - and the others on the way
2021 Apr 17	BBC	Covid vaccines: How fast is progress around the world?
2021 Jan 22	BBC	Africa's long wait for the Covid-19 vaccine	Sharing of the vaccines with the poor countries-shortcomings
2021 Jan 28	BBC	Covid-19 vaccines: Is it OK to get a leftover jab?	What is leftover jab? A vaccine dose is left over when a patient who was scheduled to receive a jab fails to show up for their appointment. Can it be used for another citizen?
2020 Oct 19	New Scientist	Covid-19 news archive: Pfizer vaccine is 95 per cent effective	Pfizer vaccine is 95 per cent effective overall and protects 94 per cent of people over 65
2021 Feb 02	New Scientist	Sputnik V vaccine is 91.6% effective against symptomatic covid-19	Russia's Sputnik V vaccine is 91.6 per cent effective at preventing symptomatic covid-19, preliminary results suggest. The vaccine has been submitted to European Union regulators for approval.
2021 Apr 13	The Hindu	U.S. recommends ‘pause' for Johnson & Johnson COVID-19 vaccine over clot reports	U.S. federal distribution channels, including mass vaccination sites, will pause the use of the Johnson & Johnson shot, and states and other providers are expected to follow
2021 Apr 13	The Hindu	India gets 3rd COVID-19 vaccine as DGCI approves Russian-made Sputnik V for emergency use	India is the most populated country to register the Russian vaccine, according to a RDIF release.
2021 Apr 12	The Hindu	China considers mixing vaccine to boost efficacy	China is considering the mixing of different COVID-19 vaccines to improve the relatively low efficacy of its existing options
2021 Mar 05	The Hindu	Efficacious too: On Covaxin	Vaccine efficacy of 80.6% for Bharat Biotech's Covaxin at phase-3 trials is promising. Hence the restricted emergency use approval of Covaxin should now be revised
2021 Feb 26	The Hindu	Vaccine inequities: On need to vaccinate all above 45	The need to vaccinate all above the age 40.
2021 Mar 13	The Hindu	A moral test: On the vaccine divide	Privileged nations must improve global availability and equitable access of vaccines
2021 Mar 15	BBC	Is Europe's AstraZeneca jab decision-making flawed?	A number of countries have decided to suspend use of the Oxford-AstraZeneca vaccine as a precaution following reports that some people have suffered blood clots after being given the jab.
2021 Jan 30	India Today	Another Covid vaccine in India? Adar Poonawalla 'hopes to launch COVOVAX by June 2021'
2021 Apr 28	The hindu	Covaxin found to neutralise 617 variant of COVID-19, says Dr. Fauci	Covaxin found to neutralise the 617 variant of Corona Virus.
2021 May 03	The Hindu	Single COVID-19 vaccine dose boosts protection in previously infected: study
2021 May 04	The new Indian Express	In Covid-19 survivors, single Pfizer dose boosts response against key strains: study
2021 May 04	Express health	First-generation vaccine good enough for new COVID-19 variants?
2021 Jan 05	WION (News Channel)	One in four people experience side effects after Covid vaccines, large-scale study finds		Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study
28-04-2021	WION (News Channel)	Covaxin found to neutralise the 617 variant of COVID-19: Dr Fauci		Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees
2021 Jun 05	WION (News Channel)	Largest study on Pfizer Covid vaccine says drug offers over 95% protection		Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
29-04-2021	WION (News Channel)	Vaccinated adults 65 and older 94% less likely to be hospitalised with COVID-19, says US CDC		Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021
2021 Jul 05	MMWR	Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine — United States, March–April 2021		Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine - United States, March-April 2021
2021 Feb 04	MMWR	Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021		Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers - Eight U.S. Locations, December 2020-March 2021
2021 Jun 05	WION (News Channel)	Moderna's trial sees progress against COVID-19 varients, brings good news and encouragement		An mRNA Vaccine against SARS-CoV-2 - Preliminary Report
23-04-2021	WION (News Channel)	One dose of Pfizer or Oxford jab reduces coronavirus infection rate by 65%, says study
30-04-2021	JAMA Network	US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021		US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021
2021 Jun 05	JAMA Network	Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers		Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers
2021 Jan 03	WION (News Channel)	Moderna's coronavirus vaccine side effects are severe, but worth it: CDC study
2021 Jan 03	WION (News Channel)	Pfizer coronavirus vaccine may be less effective in obesity: Study		OBESITY MAY HAMPER SARS-CoV-2 VACCINE IMMUNOGENICITY
27-02-2021	WION (News Channel)	Pfizer vaccine's single dose provides strong immunity to those who have had Covid-19: Study		Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose
26-04-2021	WION (News Channel)	US CDC officially recommends Covid vaccines for pregnant women		Information about COVID-19 Vaccines for People who Are Pregnant or Breastfeeding
2021 Sep 05	WION (News Channel)	COVID jabs won't raise immunity in organ transplant patients: Study		Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
2021 Jul 05	WION (News Channel)	WHO approves China's Sinopharm COVID-19 vaccine for emergency use
2021 Jun 05	WION (News Channel)	COVID-19: Russia okays single-dose Sputnik Light vaccine, has 79.4% efficacy
2021 Apr 05	WION (News Channel)	Novavax starts Covid vaccine trials on children
28-04-2021	The Hindu	One in four people experience mild side effects from Covishield vaccine: Lancet study
29-04-2021	WION (News Channel)	Young people who recovered from COVID-19 face risk of reinfection: Study
2021 Nov 05	WION (News Channel)	One AstraZeneca Covid vaccine dose cuts death risk by 80%, 2 Pfizer doses by 97%: UK agency
2021 Jun 05	The scientist	COVID-19 mRNA Vaccines Appear Effective Against Multiple Variants	Data from three studies indicate mRNA vaccines are effective against mutliple variant.The fully vaccinated had roughly 90 percent protection against severe disease with B.1.351 and B.1.1.7.
		Sputnik V in India: Vaccine to cost ₹ 995 per shot, made in India may be cheaper
14-01-2021	BBC	Covid: What do we know about China's coronavirus vaccines?
14-04-2021	BBC	Sputnik V, Covishield, Covaxin: What we know about India's Covid-19 vaccines
14-05-2021	WION (News Channel)	Sputnik V in India: Vaccine to cost ₹ 995 per shot, made in India may be cheaper
14-05-2021	WION (News Channel)	Over a quarter of EU adults would refuse COVID-19 shot, survey says
14-05-2021	WION (News Channel)	US: Fully vaccinated people can take part in indoor, outdoor activities without mask, social distancing
13-05-2021	WION (News Channel)	Double world vaccine production, Sputnik V one of the key elements, says UN chief Guterres
13-05-2021	WION (News Channel)	COVID-19: Indian medical body recommends 12-16 week gap between Covishield doses, no change for Covaxin
13-05-2021	WION (News Channel)	Pfizer and Moderna show less efficacy against double mutant discovered in India
13-05-2021	WION (News Channel)	US CDC finds more clotting cases after J&J vaccine, sees causal link
13-05-2021	WION (News Channel)	Delaying second doses of Covid vaccines can save more lives: Study
13-05-2021	WION (News Channel)	Only India has manufacturing capacity to supply COVID-19 vaccine to the world: Australian envoy to India
2021 Dec 05	WION (News Channel)	Moderna to deliver 25 mn vaccines to Australia by 2022
2021 Dec 05	WION (News Channel)	India's expert panel recommends Covaxin trials on 2-18 year-olds
2021 Dec 05	WION (News Channel)	COVID-19: Canada's largest province halts AstraZeneca first doses over blood clot
2021 May 18	BioPharm International	Sanofi and GSK Report Strong Immune Response with COVID-19 Vaccine Candidate	Recombinant COVID-19 vaccine developed by Sanofi and GSK shows strong neutralizing antibody responses in all adult age groups in a Phase II study with 722 volunteers.
2021 May 19	National Herald India	New antiviral with 99.9% efficacy against COVID-19 developed	An experimental direct-acting antiviral therapy showed 99.9% efficacy against COVID-19.
2021 Apr 09	The Hindu-	Coronavirus \| In talks with Indian govt. for clinical trial of single shot vaccine: Johnson & Johnson	Global healthcare major Johnson & Johnson is in discussions with the Indian government to begin a clinical trial of its single-dose COVID-19 vaccine in the country.
2021 Apr 20	BBC	India to start vaccinating all adults over 18 amid surge in infections	India has widened its vaccination programme as infections surge and the capital goes into lockdown.
2021 Apr 14	BBC	What are the Brazil, South Africa and UK variants and will vaccines work?